Early data from first participating employer show that SmartRx can save organizations millions by bypassing traditional PBMs to deliver brand-name GLP-1 medications NEW YOR K, April 23, 2026 Noom Health, the enterprise division of the leading behavior change platform Noom, today announced that its Smart Rx program is on pace to cut GLP-1 medication costs by nearly 80% for its first participating employer, projecting approximately $1.3M in annual spend compared to $6.2M in the prior year
JBB is a paid consultant to Anji Pharmaceuticals, Boehringer Ingelheim, Eli Lilly, Fortress Biotech, Janssen, Mellitus Health, Moderna, Pendulum Therapeutics, Praetego, ReachMD, Stability Health and Zealand Pharma
Insulin helps control blood sugar levels by helping cells absorb glucose for energy
This difference between oral and intravenous glucose is called the Incretin Effect